mercredi 8 août 2012

Clinical Chemistry Procedures To Dominate The Us Diagnostics Market




According to a new research report by RNCOS, titled US Diagnostic Market Outlook 2014, the US diagnostic industry has an important share in the global diagnostic market. The key factors that reflect a bright future for the US diagnostic market include the prevalence of several chronic and infectious diseases, emergence of innovative diagnostic technologies in cancer and infectious diseases and increasing acceptance of self-diagnosis products.





Our study revealed that the demand for clinical chemistry procedures will continue to dominate the US Diagnostics Market. Factors backing this development include an aging population and an increasing emphasis on preventive health care along with the rising awareness about the cardiac markers amongst the patients. Thus, the demand for clinical chemistry products in the US is anticipated to grow at a CAGR of around 6% during 2010-2014.





The report evaluates the potentials of the US diagnostic market and identifies future growth opportunities. It also provides extensive research and analysis on the current market trends and future forecasts on all prominent diagnostic techniques including POCT, clinical chemistry, immunoassays, blood testing, and molecular diagnostics.





We have also conducted an in-depth analysis of the regulatory environment in the US diagnostics industry which indicates that favorable re-imbursement regime for various clinical diagnostic segments and significant investments made by private firms in the research and development will dramatically fuel the growth of the industry in the coming years.





Further, the report facilitates information/statistics on the market developments in laboratory applications and disease indications. Projections made on market future scenario will help clients to take informed and proactive business decisions in the fast growing US diagnostic market. Overall, the report is meant to provide an optimum source of knowledge and analysis on the US diagnostics market to clients and investors.





For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM298.htm





Some of our Related Reports are:





- US Glucose Monitoring Market Analysis (http://www.rncos.com/Report/IM311.htm)



- UAE Healthcare Sector Forecast to 2012 (http://www.rncos.com/Report/IM224.htm)



- Brazil Healthcare Market Analysis (http://www.rncos.com/Report/IM261.htm)



- US Healthcare IT Market Analysis (http://www.rncos.com/Report/IM321.htm)



- US Medical Imaging Devices Market (http://www.rncos.com/Report/IM355.htm)





Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm





About RNCOS:





RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.


Aucun commentaire:

Enregistrer un commentaire